Little did I realize a few grapes could send my blood sugar soaring until I tried the first glucose monitor without a ...

Nearly 40 million Americans have diabetes, and nearly half of those are people who have Type 2 diabetes and are aged 65 or older. This population has a higher risk of ...

A team of engineers at the University of California San Diego has created an electronic finger wrap that monitors vital ...

The FDA has designated the Eversense 365 an integrated CGM, allowing for integration with compatible medical devices. The ...

Type 2 diabetes is characterized by the body's inability to use insulin effectively. Insulin is a hormone that helps regulate metabolism properly. The condition is the most common type of ...

As the use of electronic devices continues to rise, the management of electronic waste (e-waste) has become a critical issue.

If a patient receives a continuous glucose monitor device through their medical benefit, they may be more adherent and may ...

These devices are increasingly popular in diabetes management and health monitoring. As previously announced, Trinity Biotech has entered into a non-binding Letter of Intent with Bayer for the launch ...

Leveraging rapid technological advances for human health is a global trend, driving the rise of biomedical engineering ...

Senseonics (NYSE:SENS) announced today that it received FDA clearance for its next-generation Eversense 365 CGM system.

The U.S. FDA cleared Senseonic Holdings Inc.’s Eversense 365, the first continuous glucose monitor to last a full year with a single sensor rather than the 10 days to two weeks typical for wearable ...

The FDA has cleared Senseonics and Ascensia Diabetes Care's Eversense 365 Glucose Monitoring System. This system is designed for Type 1 and Type 2 diabetics 18 and older and will be the first ...